(19)

(11)

EP 0 956 044 A1

(12)

(43) Date of publication: 17.11.1999 Bulletin 1999/46 (21) Application number: 97930120.0 (22) Date of filing: 13.06.1997

(51) International Patent Classification (IPC):  A01K 67/ 027( . ) A61K 39/ 395( . ) A61K 47/ 48( . ) A61P 43/ 00( . ) C07K 14/ 715( . ) C12N 5/ 10( . ) A61K 38/ 00( . ) A61K 45/ 00( . ) A61P 31/ 18( . ) C07K 14/ 16( . ) C07K 16/ 28( . ) C12N 15/ 09( . ) (86) International application number: PCT/US1997/010619 (87) International publication number: WO 1997/047319 (18.12.1997 Gazette 1998/02)

(84) Designated Contracting States: AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE (30) Priority: 14.06.1996 US 19960665090 14.06.1996 US 19960019941P (71) Applicants: PROGENICS PHARMACEUTICALS, INC. Tarrytown, NY 10591 (US) AARON DIAMOND AIDS RESEARCH CENTRE (ADARC) New York, NY 10016 (US)	(72) Inventors: ALLAWAY, Graham, P. Mohegan Lake, NY 10547 (US) DRAGIC, Tatjana Hartsdale, NY 10530 (US) LITWIN, Virginia, M. Fayetteville, NY 13066 (US) MADDON, Paul, J. New York, NY 10032 (US) MOORE, John, P. New York, NY 10021 (US) TRKOLA, Alexandra, Aaron Diamond AIDS Res. Centre New York, NY 10016 (US) (74) Representative: VOSSIUS & PARTNER  Postfach 86 07 67 81634 München 81634 München (DE)